Rare diseases
Investigational molecules
Locations
Calle De Manuel Pombo Angulo 28, 28050 Madrid, Spain
Research activity includes rheumatoid arthritis in adults receiving methotrexate, with attention to inflammatory joint disease and immune-mediated pathology. The programme also reflects interest in biosimilar development for established TNF inhibitor therapy.
These studies place rheumatology and biologic therapy at the centre of the sponsor’s clinical research portfolio.
Mabxience Research S.L. runs clinical trials in conditions such as Malignant melanoma, Rheumatoid arthritis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A Study Comparing MB11 and Nivolumab in Adults With Previously Untreated Advanced or Metastatic Melanoma
GreeceStudy comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
